Methotrexate Completed Phase 3 Trials for Chronic Myeloid Leukemia (CML) / Acute Lymphoblastic Leukaemias (ALL) / Acute Myelocytic Leukemia / Myelodysplastic Syndrome / Hodgkins Disease (HD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01188798Methotrexate or Pentostatin for Graft-versus-host Disease Prophylaxis in Risk-adapted Allogeneic Bone Marrow Transplantation for Hematologic Malignancies
NCT02042690Haplo-identical HSCT Versus Chemotherapy for Adult Acute Lymphoblastic Leukemia Patients
NCT00165178Treatment of Acute Lymphoblastic Leukemia in Children
NCT00187083A Study of Children With Refractory or Relapsed ALL
NCT00137111Therapy for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia